Karl Tronstad: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (→Notable ME/CFS studies: add) |
Notjusttired (talk | contribs) m (ref improve) |
||
Line 1: | Line 1: | ||
[[File:Karl Tronstad.png|200px|thumb|right]] | [[File:Karl Tronstad.png|200px|thumb|right]] | ||
'''Karl Johan Tronstad''', PhD, is a professor in the Department of Biomedicine, University of Bergen, Bergen, Norway, where he heads the Tronstad Lab which studies cell metabolism and mitochondrial involvement in cancer and [[Myalgic Encephalomyelitis]]/[[Chronic Fatigue Syndrome]] ([[ME/CFS]]). In 2017, his research group received a grant of 9.5 million for the development of new [[ME/CFS]] treatment methods and biomarkers. Dr. Tronstad collaborates with Professor [[Olav Mella]] and [[Øystein Fluge]] at the Department of Oncology and Medical Physics at Haukeland University Hospital on [[ME/CFS]] research.<ref> | '''Karl Johan Tronstad''', PhD, is a professor in the Department of Biomedicine, University of Bergen, Bergen, Norway, where he heads the Tronstad Lab which studies cell metabolism and mitochondrial involvement in cancer and [[Myalgic Encephalomyelitis]]/[[Chronic Fatigue Syndrome]] ([[ME/CFS]]). In 2017, his research group received a grant of 9.5 million for the development of new [[ME/CFS]] treatment methods and biomarkers. Dr. Tronstad collaborates with Professor [[Olav Mella]] and [[Øystein Fluge]] at the Department of Oncology and Medical Physics at Haukeland University Hospital on [[ME/CFS]] research.<ref>{{Cite web|url=https://www.uib.no/biomedisin/108972/finding-cause-chronic-fatigue-syndromeme|title=Finding the cause of Chronic Fatigue Syndrome/ME|website=University of Bergen|language=en|access-date=2021-03-07}}</ref> | ||
==Notable studies== | ==Notable studies== | ||
Line 54: | Line 54: | ||
| pmid = | | pmid = | ||
| doi = 10.1172/jci.insight.89376 | | doi = 10.1172/jci.insight.89376 | ||
}} | |url=https://doi.org/10.1172/jci.insight.89376|pages=|chapter=|edition=|isbn=}} | ||
</ref> | </ref> | ||
</references> | </references> |
Revision as of 13:23, March 7, 2021
Karl Johan Tronstad, PhD, is a professor in the Department of Biomedicine, University of Bergen, Bergen, Norway, where he heads the Tronstad Lab which studies cell metabolism and mitochondrial involvement in cancer and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). In 2017, his research group received a grant of 9.5 million for the development of new ME/CFS treatment methods and biomarkers. Dr. Tronstad collaborates with Professor Olav Mella and Øystein Fluge at the Department of Oncology and Medical Physics at Haukeland University Hospital on ME/CFS research.[1]
Notable studies[edit | edit source]
- 2016, Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome[2] (Full Text)
- 2020, Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study[3] - (Full text)
Talks and interviews[edit | edit source]
- 2019, Speaker at the 14th Invest in ME International ME Conference; Speech title: Metabolic profiling and associations to clinical data in ME - (Video)
Online presence[edit | edit source]
Learn more[edit | edit source]
See also[edit | edit source]
References[edit | edit source]
- ↑ "Finding the cause of Chronic Fatigue Syndrome/ME". University of Bergen. Retrieved March 7, 2021.
- ↑ Fluge, Øystein; Mella, Olav; Bruland, Ove; Risa, Kristin; Dyrstad, Sissel E.; Alme, Kine; Rekeland, Ingrid G.; Sapkota, Dipak; Røsland, Gro V.; Fosså, Alexander; Ktoridou-Valen, Irini; Lunde, Sigrid; Sørland, Kari; Lien, Katarina; Herder, Ingrid; Thürmer, Hanne; Gotaas, Merete E.; Baranowska, Katarzyna A.; Bohnen, Louis M.L.J.; Schäfer, Christoph; McCann, Adrian; Sommerfelt, Kristian; Helgeland, Lars; Ueland, Per M.; Dahl, Olav; Tronstad, Karl J. (2016), "Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome", JCI Insight, 1 (21), doi:10.1172/jci.insight.89376
- ↑ Rekeland, Ingrid G.; Fosså, Alexander; Lande, Asgeir; Ktoridou-Valen, Irini; Sørland, Kari; Holsen, Mari; Tronstad, Karl J.; Risa, Kristin; Alme, Kine; Viken, Marte K.; Lie, Benedicte K.; Dahl, Olav; Mella, Olav; Fluge, Øystein (2020). "Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study". Frontiers in Medicine. 7 (162). doi:10.3389/fmed.2020.00162. ISSN 2296-858X.